Form 4 for GH Guardant Health, Inc.
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-05 · accession 0001336504-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-12-08 | 2025-12-05 | GH | CLARK IAN T | Dir | M - OptEx | $35.83 | +28.6K | 38.5K | +290% | +$1.03M |
| DMI | 2025-12-08 | 2025-12-05 | GH | CLARK IAN T | Dir | S - Sale+OE | $107.19 | -28.6K | 13.3K | -68% | -$3.07M |
| DM | 2025-12-08 | 2025-12-05 | GH | CLARK IAN T | Dir | M - OptEx | $0.00 | -28.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | M | A | 9,105 | $38.42 | 18,956 | I By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account | — | — | |
| 2 | Common | Common Stock | 2025-12-05 | M | A | 8,803 | $38.01 | 27,759 | I By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account | — | — | |
| 3 | Common | Common Stock | 2025-12-05 | S | D | 3,400 | $108.05 | 9,851 | I By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account | — | — | (F3) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.885 to $108.480. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Common | Common Stock | 2025-12-05 | S | D | 8,156 | $106.67 | 30,306 | I By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account | — | — | (F1) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.88 to $106.87. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2025-12-05 | S | D | 17,055 | $107.27 | 13,251 | I By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account | — | — | (F2) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.88 to $107.87. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 6 | Common | Common Stock | 2025-12-05 | M | A | 10,703 | $31.84 | 38,462 | I By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-12-05 | M | D | 9,105 | $0.00 | 0 | D | $38.42 · — to 2032-06-15 | 9,105 Common Stock | (F4) The Stock Options vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier. |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-12-05 | M | D | 10,703 | $0.00 | 0 | D | $31.84 · — to 2034-06-12 | 10,703 Common Stock | (F6) The stock option vests in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier. |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-12-05 | M | D | 8,803 | $0.00 | 0 | D | $38.01 · — to 2033-06-14 | 8,803 Common Stock | (F5) The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier. |